Synthetic Natural Killer Cells for Immunotherapy

Project Information

SYNKIT

Grant agreement ID: 838909

DOI

10.3030/838909

Project closed

EC signature date 19 March 2019

Start date 1 September 2020

End date 31 August 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 191 852,16

EU contribution

€ 191 852,16

Coordinated by

KAROLINSKA INSTITUTET
Sweden

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Other (1)

Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells

Author(s): Quirin Hammer, Karlo Perica, Hanna van Ooijen, Rina Mbofung, Pouria Momayyezi, Erika Varady, Karen E. Martin, Yijia Pan, Mark Jelcic, Brian Groff, Ramzey Abujarour, Silje Krokeide, Tom Lee, Alan Williams, Jode P. Goodridge, Bahram Valamehr, Björn Önfelt, Michel Sadelain, Karl-Johan Malmberg.
Published in: bioRxiv preprent server, 2023
Publisher: CSH
DOI: 10.1101/2023.10.09.557143

Peer reviewed articles (4)

Engineering immune-evasiveallogeneic cellular immunotherapies

Author(s): Karen E. Martin 1,2,6, Quirin Hammer 3,6, Karlo Perica4,5,6, Michel Sadelain 4 & Karl-Johan Malmberg 1,2,3
Published in: Nature Reviews Immunolgy, 2024, ISSN 1474-1733
Publisher: Nature Publishing Group
DOI: 10.1038/s41577-024-01022-8

Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene Analyses

Author(s): Pouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
Published in: Current Protocols, Issue 2(11), 28 Nov 2022, 2022, ISSN 2691-1299
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/cpz1.613

An optimized platform for efficient siRNA delivery into human NK cells

Author(s): Daniel Palacios, Pouria Momayyezi, Oisín Huhn, Eivind Heggernes Ask, Josefine Dunst, Karl-Johan Malmberg, Quirin Hammer
Published in: Eur J Immunol, 2022, ISSN 1521-4141
Publisher: Wiley
DOI: 10.1002/eji.202149710

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies

Author(s): Quirin Hammer 1 9 , Karlo Perica 2 3 4 9 , Rina M. Mbofung 5 , Hanna van Ooijen 6 , Karen E. Martin 7 8 , Pouria Momayyezi 1 , Erika Varady 5 , Yijia Pan 5 , Mark Jelcic 5 , Brian Groff 5 , Ramzey Abujarour 5 , Silje Z. Krokeide 7 8 , Tom Lee 5 , Alan Williams 5 , Jode P. Goodridge 5 , Bahram Valamehr 5 , Björn Önfelt 1 6 , Michel Sadelain 3 , Karl-Johan Malmberg 1 7 8 10
Published in: Cell Stem Cell, 2024, ISSN 1934-5909
Publisher: Cell Press
DOI: 10.1016/j.stem.2024.06.011